Note: Descriptions are shown in the official language in which they were submitted.
CA 02659948 2009-02-03
WO 2008/015203 PCT/EP2007/057861
COMPOSITIONS OF MICROPARTICLES AND GRANULES FOR
ORAL CONTROLLED RELEASE OF SUBSTANCES FOR
VETERINARY USE
Technical Field
The present invention discloses compositions for preparing
microparticles or granules intended for use in the zootechnical field, for the
controlled release of one or more substances having a pharmacological
action, food supplements or diagnostic media, suitable for oral
administration, and the method for producing said microparticles or
granules.
Background Art
The oral administration of active substances in the zootechnical field
is a problem which is not easy to solve, in particular as regards the
possibility to ensure intestinal absorption of adequate doses of said
substances, avoiding their massive degradation during passage through the
digestive tract of the animal, especially in the case of ruminants.
The aspects of the physiology of the digestive tract of ruminants and
of other so-called companion animals or productive livestock are disclosed
in detail in many specialist monographs. Among these, some also review the
problems linked to the oral administration of active ingredients in such
animals, as well as the possible solutions in terms of formulation technology
(Development and formulation of veterinary dosage forms 2nd Edition,
G.E. Hardee, ID. Baggot (Edts) Marcell Dekker, New York 1998; S.H.W.
Wu, A. Papas, Rumen stable delivery systems, Advanced drug delivery
reviews 28 (1997) 323-334). The active ingredients and the supplements of
the animal's diet undergo, in the proximal tract of the digestive systein, an
enzymatic and chemical degradation before reaching the intestinal lumen,
which is the site of absorption for said substances. In ruminants, this
degradation is particularly substantial due to the presence, in the rumen, of
a
microflora which degrades effectively many of the substances which pass
CA 02659948 2009-02-03
WO 2008/015203 PCT/EP2007/057861
through the rumen. One must also consider the slowness with which said
substances pass through the rumen. This causes only a small part of the
active substances or food supplements to be absorbed by ruminants at the
intestinal level, since almost 100% of these molecules is degraded by the
microflora of the rumen. Therefore, to allow such substances to be absorbed
in the intestine and apply their effectiveness, it is necessary to protect
them
against degradation at the rumen level. It is in fact known that for example a
substance such as choline or its salts are capable of increasing milk
production in bovines when they are administered directly at the post-rumen
level (S.R. Haretewell et al., J Dairi Sci. (2000) 83, 2097-2017 and K.N.
Deulcher et al., J. Dairi Sci., (1998) 81, 238-242).
US-4,533,557, granted to Nippon Soda Ltd, discloses the composition
of food supplements for ruminants in the fonn of granules or tablets which
contain a mixture of biologically active substances, chitosan and protective
materials constituted by saturated or unsaturated aliphatic monocarboxylic
acids, with a chain having 14 to 22 carbon atoms. The concept behind this
invention consists in using hydrophobic substances to build a matrix which
is capable of slowing the penetration of biological fluids inside it and
consequently of causing a slower release of the substance. The aim is
therefore to extend the substance release time by reducing the amount
thereof released during rumen transit. Further, the presence of chitosan
should provide specific protection against the rumen environment: the pH of
the fluid contained in the rumen varies between 5 and 8; chitosan is scarcely
soluble in this pH range, but dissolves instead in an acid pH (<5). Therefore,
the presence of this type of polymer should give greater integrity to the
matrix during rumen holding.
US-5,190,775, granted to the Balchem Corporation, discloses the
composition of particles or granules for oral administration having a relative
density between 0.3 and 2 g/ml, which contain a bioactive substance which
is encapsulated by ineans of a hydrophobic coating which is constituted
CA 02659948 2013-02-06
3
preferably by hydrogenated vegetable oils coated on their surface with a layer
of surfactant in
order to prevent its floating within the rumen. In the specific case in which
the bioactive
substance is choline chloride, it is adsorbed on a vegetable substrate derived
from cereals.
In another patent, granted to Morgan Manufacturing Co., Inc. (US-5,496,571), a
method is disclosed for manufacturing microcapsules which are intended for
oral
administration and are designed to protect choline chloride against
degradation caused by
rumen bacteria in order to increase the production of milk in ruminants. These
microcapsules
contain liquid compositions of choline chloride coated with an outer layer of
lipid material
selected among hydrogenated and non-hydrogenated animal fats or among
hydrogenated
vegetable oils.
A series of other patents claims methods and compositions which entail coating
a
core which contains a bioactive substance by way of materials which are
capable of
withstanding at least partly rumen degradation and of dissolving and/or
degrading in the
abomasus or in the distal part of the intestine of ruminants. Among these
patents, mention
can be made for example of US-4,713,245, US-3,541,204, and US-4,876,097.
US-4,832,967, granted to Rhone Poulenc Sante, claims a composition for feeding
ruminants which is constituted by a core which contains the bioactive
substance, coated by
two protective layers. The first of said coatings is a polymeric substance
which is capable of
forming a film which is stable at pH > 5 but is capable of releasing the
bioactive substance at
pH <3.5. The second coating is a hydrophobic substance.
The preparation of multilayer polymeric microspheres for controlled release of
drugs,
fertilizers, insecticides and chemical indicators is claimed by US-5,912,017,
granted to the
Massachusetts Institute of Technology.
In US Patent Publication No. 2005/0019413, Ascor Chimici S.r.l. claims a
composition in the form of particles which contain choline chloride
administered in a rumen-
protected form. The particles are constituted by a core which consists
CA 02659948 2013-02-06
4
mainly of choline chloride in the form of crystalline powder, coated by a
double protective
layer: externally, a continuous layer of carnauba wax and internally a
continuous layer of a
hydrophobic substance such as hydrogenated soybean oil. Moreover, the core can
contain
additional substances acting as flow modifiers (silicate, aluminosilicates,
zeolites, silica,
pearlite) in amounts not exceeding 8% of the weight of the core, and/or acting
as binding
agents which have a barrier function against moisture (stearates) in an amount
equal to 7% of
the weight of the core.
In a second patent application (US Patent Publication No. 2006/0067984), the
same
Ascot Chimici S.r.l. claims the invention of compositions in the form of
pellets for controlled
release of physiologically active substances for zootechnical use. These
compositions
comprise: i) a core constituted by the physiologically active substance and by
a matrix of
carnauba wax and/or microcrystalline wax; ii) a first hydrophobic coating
layer, which
consists of a material which belongs to the category of fats, fatty acids,
hydrogenated oils,
fatty acid mono- or diglycerides, fatty acid esters or long-chain alcohols (12
to 22 carbon
atoms), with a melting point between 40 and 74 C; iii) a second coating layer
over the first
one, which is constituted by microcrystalline waxes, paraffin waxes, vegetable
waxes and
synthetic waxes with a melting point between 80 and 100 C.
One of the claims further specifies that the matrix that constitutes the core
can also
contain hydrophobic silicates.
Disclosure of the Invention
The aim of the present invention is to provide compositions in the form of
microparticles or granules intended for use in the zootechnical field and/or
more generally in
the veterinary field which are capable of controlling, by slowing it, the
release in the
gastrointestinal tract of animals, particularly ruminants, of one or more
substances which
have a pharmacological action, food supplements or diagnostic media, said
substances being
characterized by the presence, within their chemical
CA 02659948 2009-02-03
WO 2008/015203 PCT/EP2007/057861
structure, of a cationic function or an anionic function or of a neutral but
easily ionizable function in order to obtain a net charge. In such
compositions, the substance or substances carried by the microparticles or
granules are protected against the degradation that can occur in the first
part
5 of the
gastrointestinal tract, in particular in the rumen, and can instead be
released and absorbed in the intestine.
A specific characteristic of the method for preparing the compositions
disclosed in the present invention relates to the fact that the preparation of
said microparticles or granules occurs without using organic solvents.
Within this aim, an object of the present invention is to provide
microparticles or granules which have technological and chemical-physical
characteristics which are adapted to avoid their degradation during
processes for the industrial production of pharmaceutical products or feeds
(for example mixing with other ingredients, heating, application of
pressure).
This aim and this and other objects, which will become more clear
from the description that follows of the invention, are achieved by the
system for the controlled release of one or more physiologically or
pharmacologically active substances, represented by compositions in the
form of microparticles or granules having a size between 0.1 and 5000
microns and intended for use in the zootechnical field and/or more generally
in the veterinary field, constituted by a core which contains one or more
substances having a phartnacological action, food supplements or diagnostic
media, said substance or substances being characterized by the presence,
within their chemical structure, of a cationic function or of an anionic
function or of a function which is neutral but can be easily ionized in order
to obtain a net charge, intimately mixed or adsorbed with a hydrated silicate
of magnesium, aluminum, calcium and sodium (smectite, montmorillonite or
bentonite), hereinafter referenced simply as silicate, which is capable of
absorbing water and causing reversible swelling; said core is coated by a
CA 02659948 2009-02-03
WO 2008/015203 PCT/EP2007/057861
6
double fatty layer constituted by two fats or waxes, in which the one having
the highest melting point constitutes the inner layer (in contact with the
core) while the one having the lowest melting point is arranged so as to
form the outer layer.
Ways of carrying out the Invention
Examples of substances with a cationic function or a neutral but
easily ionizable function suitable for the purpose cited above are: choline
and its salts, particularly choline chloride, betaine, betaine hydrochloride,
methionine hydrochloride, carnitine hydrochloride, lysine hydrochloride,
thiamine hydrochloride, thiamine mononitrate, pyridoxine hydrochloride,
calcium chloride, calcium sulfate, streptomycin, colistin sulfate, tiamulin
fumarate, neomycin arginine, glucosamine, niacinamide and salts thereof,
particularly the sulfate.
The core of the microparticles or granules according to the present
invention can also be constituted by active substances characterized by the
presence, within their chemical structure, of an anionic function or of a
function which is neutral but can be ionized easily, such as for example but
not 'imitatively, citric acid, malic acid, lactic acid, ascorbic acid,
nicotinic
acid intimately mixed or adsorbed with one or more excipients containing a
cationic chemical function, selected for example but not 'imitatively among
cationic starches, cationic derivatives of cellulose, acrylic polymers with
amine groups, chitosan, clay derivatives. Such core is coated by a double
layer of fat, constituted by two fats or waxes, of which the one with the
highest melting point constitutes the inner layer while the one with the
lowest melting point is arranged so as to form the outer layer. The ability to
control release effectively is determined by the synergistic action of two
phenomena: an interaction between the active substance and the excipient or
excipients of the core, and the barrier effect of the double fat layer.
The controlled-release system according to the present invention is
provided by preparing microparticles or granules with a method which is
CA 02659948 2009-02-03
WO 2008/015203 PCT/EP2007/057861
7
composed of the following steps:
¨ preparing a mixture of powders which comprises the active
ingredient or ingredients and the silicate. The amount of silicate is
comprised between 20 and 80% and preferably between 30 and 70%, even
more preferably between 35 and 55% of the weight of the mixture.
Optionally, the mixture can also contain excipients capable of improving the
formation of granules or microgranules, such as for example
microcrystalline cellulose, polyvinylpyrrolidone, calcium phosphate, in an
amount comprised between 2 and 20% of the weight of the mixture. Mixing
can be performed with ordinary fixed- or rotating-body mixers, since the
choice of the type of mixer is not particularly critical with respect to the
intended result. Starting from said mixture, microgranules or granules are
formed by adding water in a quantity which is sufficient to achieve
agglomeration but not a cohesive mix; the amount of water that is added is
comprised between 5 and 50%, more preferably between 10 and 30%, and
even more preferably is 20% of the weight of the mixture of powders. The
process for forming the granules or microgranules can be performed with
the techniques commonly described for processes for granulation or
agglomeration in the pharmaceutical field and in the food or fodder
industry. Examples in this regard are described abundantly in specialist
literature, such as for example in Pharmaceutical principles of solid dosage
forms, J.T Carstensen (Ed.) (1993), Technomic Publishing Co., Lancaster
(USA), or Pharmaceutical Pellettization Technology I. Ghebre-Sellassie
(Ed.) (1989), Marcel Dekker, New York (USA), or Principi di tecnologie
farmaceutiche, P. Colombo et al. (Eds.) (2004), Casa Editrice Ambrosiana,
Milan (Italy), and are represented for example by the processes of extrusion-
spheronization, fluid-bed granulation, rotating plate granulation, high-speed
granulation, wet granulation.
In terms of use for the purposes of the present invention, the
granulation methods that can be used are those that allow to use water or an
CA 02659948 2009-02-03
WO 2008/015203 PCT/EP2007/057861
8
aqueous solution to facilitate contact between the active ingredient or
ingredients and the silicate.
As an alternative to the method described above, the powder of the
silicate can be transformed into granules or microgranules by spraying it or
mixing it with an aqueous solution which contains the active ingredient or
ingredients. In this case, the concentration of said solution is comprised
between 0.05 and 0.95 g/m1 and preferably between 0.2 and 0.8 g/m1 and
even more preferably between 0.5 and 0.75 g/ml.
In this case also, it is optionally possible to add to the silicate
excipients which are capable of improving the formation of granules or
microgranules, such as for example microcrystalline cellulose,
polyvinylpyrrolidone, calcium phosphate, starch, in an amount comprised
between 1 and 15% of the weight of the silicate.
The amount of solution of active substance that is added is such that
the amount of active ingredient is comprised between 80 and 20 parts by
weight and preferably between 70 and 30 parts by weight, even more
preferably between 65 and 45 parts by weight.
In this case also, the method for producing the granules can be for
example extrusion-spheronization, fluid-bed granulation, rotating plate
granulation, high-speed granulation, and wet granulation.
In both of the production methods described above, once the granules
or microgranules have been obtained, they are dried if necessary with a
drying method which uses a static or dynamic bed.
The granules thus obtained are coated with a layer of vegetable-
derived fat which has a melting point comprised between 63 and 90 C and
preferably equal to 65 C. The preferred fat is constituted by mixtures of
partially hydrogenated fatty acid triglycerides or by a mixture of free fatty
acids, with chains having 14 to 20 carbon atoms, preferably C16 and C18.
In particular, the preferred conditions provide for a content of C16 fatty
acid
triglycerides comprised between 10 and 30% and of C18 comprise between
CA 02659948 2009-02-03
WO 2008/015203 PCT/EP2007/057861
9
65 and 90% of the total fatty acid content.
Said fat can be applied to the surface of the cores prepared as
described earlier, after melting said fat, by means of a so-called fluid bed
or
spray congealing technique or by drum mixer coating or in any case with a
coating method such as those shown for example in the monograph Coated
pharmaceutical dosage forms. Fundamentals, manufacturing techniques,
biopharmaceutical aspects, test methods and raw materials, K.H. Bauer, K.
Lehmann, H.P. Hosterwald, G. Rothgang (Edts), CRC Press, Boca Raton
1998 .
The coated cores thus obtained are subjected to a second coating with
a vegetable fat which has a melting point comprised between 58 and 63 C
and preferably between 59 and 62 C. The fat is constituted preferably by
mixtures of partially hydrogenated fatty acid triglycerides or a mixture of
free fatty acids, with a chain of 14 to 20 carbon atoms, preferably C16 and
C18. In particular, the preferred conditions provide for a C16 fatty acid
triglyceride content comprised between 35 and 55% and C18 between 45
and 60% of the total fatty acid content. The technique for applying the
second coating layer is similar to the one used for the first one.
The total amount of coating applied is between 15 and 65% and
preferably between 30 and 60% of the final weight of the granules or
microparticles, said quantity being distributed between the first and second
coating layers in a ratio comprised between 1:2.5 and 1:0.5.
A particular characteristic of the present invention is that it has been
found surprisingly that the ability to control effectively the release, and
consequently reduce the rumen degradation, of active substances which
contain a cationic or anionic chemical function is determined by the
synergistic action of two phenomena: an interaction between the active
substance and the other component of the core; and the barrier effect of the
double fat layer. Considered individually, the two phenomena are unable to
control effectively the release of the active substance.
= CA 02659948 2013-02-06
The ability of the silicates cited in the present invention to adsorb in water
substances
which have a cationic function in their chemical structure is in fact known
(FS. Grazy et al.,
Pharmazie (1984), 39, 821-3). However, this phenomenon alone is not sufficient
to control
effectively the release of substance from the microparticles, and likewise
adequate control of
5 the release rate of active substances (in particular those characterized
by high water
solubility) is not achieved by applying a double coating as described above to
cores
constituted by a supporting material which is unable to give rise to said
interaction or which
causes a too bland interaction. The type of silicate and the amount to be used
are a significant
aspect which characterizes the present invention in relation to what is
disclosed in the patents
1() cited above.
Another specific characteristic of the present invention is constituted by the
presence
of a coating around the core that contains the active substance, which is
constituted by two
layers. Differently from patent applications US Patent Publication No.
2005/0019413 and US
Patent Publication No. 2006/0067984, the coating layer constituted by the
material having
the highest melting point is in direct contact with the core, while the layer
constituted by the
material having the lowest melting point is arranged on the outside of the
granule or
microparticle. This is an unquestionable advantage in terms of production
method, since it
allows to apply the two layers sequentially, preventing the layer in contact
with the core from
being damaged by even partial melting during the application of the second
layer.
By way of non-limiting demonstration, examples related to the preparations and
characteristics of the invention are cited hereafter.
Example 1
700 g of bentonite (Laviosa, Livorno, IT) were mixed with 1100 g of choline
chloride
crystals (Amik, Milano, IT) and 16 ml of purified water in the chamber of a
rotary
granulating machine of the RotoJ type (Zanchetta, Lucca, IT), applying a
mixing speed of
200 rpm for 1 hour in order to
CA 02659948 2009-02-03
WO 2008/015203 PCT/EP2007/057861
11
facilitate adsorption of the choline on the bentonite. A vacuum drying step
(chamber pressure 0.2 bar) was then performed with a chamber temperature
of 40 C at 100 rpm.
The resulting granules were then sorted with a screen having a 2.8-
inm mesh pitch in order to eliminate any agglomerations of excessive size.
Said granules represent the cores subsequently subjected to coating.
11.4 g of said granules were rolled in a drum mixer with a volume of
1 1, heated to the temperature of 65 C with 4.3 g of a powder of a vegetable
fat, constituted by a mixture of triglycerides which had the following
percentage composition in fatty acid residues: C14, 1; C16, 15; C18, 83;
C18', 0.8; C20, 0.4 (Eulip, Parma, IT). The drum mixer was made to roll and
heated to said temperature until a layer of fat was distributed completely
over the granules. After cooling, the resulting coated granules received the
addition of 4.3 g of a powder of a vegetable fat, constituted by a mixture of
triglycerides having the following percentage composition in fatty acid
residues: C14, 1; C16, 45; C18, 53; C18', 0.5; C20, 04 (Eulip, Parma, IT).
The drum mixer was made to roll and heated to the temperature of 59 'V
until a layer of fat was distributed completely over the granules. Cooling
caused the complete solidification of the second layer of fat.
Comparison Example 2
Granules coated according to the method described in Example 1
were prepared by way of comparison, using micronized silica (Degussa AG,
Frankfurt am Main, Germany) instead of bentonite to form the core
subsequently coated as described above.
Comparison Example 3
Granules coated according to the method described in Example 1
were prepared by way of comparison by using corn cob instead of bentonite
to form the core subsequently coated as described above.
Comparison Example 4
Uncoated granules obtained according to the method described in
CA 02659948 2009-02-03
WO 2008/015203 PCT/EP2007/057861
12
Example 1 as regards core preparation were prepared by way of comparison.
Example 5
650 g of sodium calcium bentonite (Dal Cin, Milan, IT) were mixed
with 44 g of microcrystalline cellulose (FMC, Philadelphia, USA) at 100
rpm in the chamber of a rotary granulating machine of the RotaT type
(Zanchetta, Lucca, IT). 960 g of choline chloride crystals (Amik, Milano,
IT) and 20 ml of purified water were then added, applying a mixing speed of
200 rpm for 1 hour to facilitate adsorption of the choline on the bentonite.
Subsequently, a step of vacuum drying was performed (chamber pressure
0.2 bars) with a chamber temperature of 50 C at 100 rpm.
The granules thus obtained were sorted with a screen having a 3.5
inm mesh pitch in order to eliminate any agglomerations of excessive size.
13 g of said granules were rolled in a drum mixer having a volume of
1 1, heated to 65 C with 2 g of a powder of a vegetable fat constituted by a
mixture of triglycerides having the following percentage composition in
terms of fatty acid residues: C14, 1; C16, 15; C18, 83; C18', 0.8; C20, 0.4
(Eulip, Parma, IT). The drum mixer was made to roll and heated to said
temperature until a layer of fat was distributed completely over the granules.
After cooling, the coated granules thus obtained received the addition of 5 g
of a powder of a vegetable fat constituted by a mixture of triglycerides
having the following percentage composition in fatty acid residues: C14, 1;
C16, 45; C18, 53; C18', 0.5; C20, 0.4 (Eulip, Parma, IT). The drum mixer
was made to roll and heated to 59 C until a layer of fat was distributed
completely over the granules. Cooling produced complete solidification of
the second layer of fat.
Example 6
The coated granules prepared as described in Examples 1-5 (500 mg)
were subjected to a test to determine the release rate of the choline chloride
by using a paddle dissolver which turned at 100 rpm (FU XI). 1 1 of
phosphate buffer at pH 7.4 (FU IX), controlled by thermostat to the
CA 02659948 2009-02-03
WO 2008/015203
PCT/EP2007/057861
13
temperature of 40 C, was used as a dissolving medium. The quantity of
choline chloride released in the various time intervals over 24 hours was
determined by measuring its concentration in the dissolving medium by way
of a previously validated HPLC method.
By way of comparison, two commercially available products,
manufactured respectively by the Balchem company (Reashure Choline)
and by the company Ascor Chimici (Sta-Chol) were also tested.
The results obtained are given in Table 1 as a percentage of choline
chloride released after 1, 3, 5, 7 and 24 hours.
Table 1
Product , Percentage of released choline chloride
õ
, 1 hour 3 hours ; 5 hours 7 hours ' 24 hours
:Example 1 0.75 4.3 7.4 10
27
Example 2 34
56
61 73 100
;Example 3 2.3 9 162
.3 ' 24.5 67.4
Example 4 100 100 100 100 100
Example 5 0 0 0 0
7
Balchem 13.2 = 23 26
27 34.7
Ascor 36.4 55.8 70.3 77 100
Chimici
It is noted that the product formulated as described in Example 1 has
an optimum release over 24 hours. The product formulated as described in
Example 5 is even more capable of controlling the release of the active
substance, ensuring prolonged rumen protection.
As regards the commercial products, they release choline chloride at a
higher rate than the formulations of Examples 1 and 5.
As regards the formulation described in Example 2, it is noted that the
CA 02659948 2009-02-03
WO 2008/015203 PCT/EP2007/057861
14
replacement of bentonite with silica determines a substantial loss of the
ability to control release, and the same occurs for the formulation described
in Example 3 by replacing the bentonite with corn cob. Finally, the use of
bentonite alone, without the double fat coating (formulation described in
Example 4), leads to immediate release of all the choline chloride.
Example 7
15.5 g of bentonite (Laviosa) were mixed in a mortar with 24.5 g of
lysine hydrochloride crystals (DSM, Milano, IT) and mixed with 2 ml of
purified water. Drying in an air circulation oven at 40 C was then
performed for 1 hour. The resulting granules were sorted with a screen
having a mesh pitch of 2.8 mm in order to eliminate any agglomerations of
excessive size. Said granules constitute the cores which were subsequently
subjected to coating in the manner and with the materials described in
Example 1.
A test was conducted on the produced granules to determine the
release rate of lysine hydrochloride in the manner described in Example 6.
The amount of lysine hydrochloride at the various time intervals was
determined by measuring its concentration in the dissolving medium by
means of a chromatographic method.
The amount of released lysine hydrochloride expressed as a
percentage of the dose that is present in the granules is given in Table 2
Table 2
Percentage of released lysine hydrochloride
0.5 hours 3 hours 7 hours 24 hours
Example 7 4.6 10 11.9 17.2
Good control in the release of lysine hydrochloride over 24 hours is
observed, such as to ensure prolonged rumen protection.
Example 8
20 g of bentonite (Laviosa, Livorno, IT) were mixed in a mortar with
CA 02659948 2009-02-03
WO 2008/015203 PCT/EP2007/057861
22 g of calcium chloride crystals (Solvay, Rosignano, IT) and mixed with 2
ml of purified water. A step of drying in an oven with air circulation at 40
C for 1 hour was then performed.
The resulting granules were sorted with a screen having a mesh pitch
5 of 2.8
mm in order to eliminate any agglomerations of excessive size. Said
granules represent the cores which were subsequently subjected to coating
in the manner and with the materials described in Example 1.
A test was conducted on the produced granules to determine the
release rate of the calcium chloride in the manner described in Example 6.
10 The amount of CaC12 at the various time intervals was determined by
measuring its concentration in the dissolving medium by colorimetry
(Calcium-Test, Merck KGaA, Darmstadt, Germany).
The ainount of released CaC12 expressed as a percentage of the dose
that is present in the granules is given in Table 3.
15 Table 3
Product Percentage of released CaC12
1 hour 3 hours 5 hours 7 hours , 24 hours
Example 8 6.4 19.5 28.8 41.7 85
It is noted a very good control in the calcium chloride release
especially in the first hours.
Example 9
The granules produced in the manner described in Example 1 were
subjected to a stability test according to ICH teachings (25 C; 60% RH).
After 1, 3 and 6 months, the granules were subjected to a dissolution
test as described in Example 6. The obtained results are given in Figure 1.
The results show that over 6 months the formulation described in
Example 1 maintains a good ability to control release, indicating good
stability of the product.
CA 02659948 2013-02-06
=
16
Example 10
40 g of bentonite AG/1W (Dal Cin, Milano, IT) were mixed in a mortar with a
solution of 50 g of citric acid (UNIVAR, Milano, IT) dissolved in 15 ml of
purified hot
water. Drying in an air circulation oven at 40 C was then performed for 1
hour.
The resulting granules were sorted with a screen having a mesh pitch of 2.8 mm
in
order to eliminate any agglomerations of excessive size. Said granules
constitute the cores
which were subsequently subjected to coating in the manner and with the
materials described
in Example 1.
A test was conducted on the produced granules to determine the release rate of
citric
acid in the manner described in Example 6. The amount of citric acid at the
various time
intervals was determined by measuring its concentration in the dissolving
medium by means
of a previously validated HPLC method. The amount of released citric acid
expressed as a
percentage of the dose that is present in the granules is given in Table 4.
Table 4
Percentage of released citric acid
0.5 hours 3 hours 7 hours 24 hours
Example 10 0 0 6.4 29.9
Very good control in the release of citric acid over 24 hours is observed,
such as to
ensure prolonged rumen protection.
